कंपनी का अवलोकन
National Health Investors, Inc. operates as a self-managed real estate investment trust focused on providing sale-leaseback, joint venture, and financing solutions specifically for need-driven and discretionary senior housing and medical facility investments. The company functions within the Real Estate sector, more precisely within the REIT - Healthcare Facilities industry, which denotes its specialization in income-producing properties related to medical care rather than general commercial or residential real estate. This entity currently maintains a market capitalization of $4.17B, reports a trailing twelve-month revenue of $379.29M, and employs 32 individuals to manage its extensive portfolio. These financial figures indicate that National Health Investors, Inc. is a significant market participant with a substantial asset base that generates nearly $380 million in annual revenue while maintaining a lean operational workforce of only 32 employees. The combination of a large market cap relative to its small employee count suggests a highly automated or asset-heavy business model where capital deployment drives value rather than extensive labor costs.
वित्तीय स्वास्थ्य
The company reported a revenue of $379.29M for the trailing twelve months, generating a net income of $141.98M and an EBITDA of $276.77M. The substantial gap between the $379.29M revenue and the $141.98M net income reveals a highly efficient cost structure where the business retains over 37% of its top-line revenue as profit, though the difference between EBITDA and Net Income highlights significant non-operating expenses or interest obligations typical of a leveraged REIT structure. Free cash flow stands at $195.47M, which represents a robust generation of liquidity that provides the company with significant financial flexibility to service its debt obligations or pursue capital allocation strategies. The gross margin is recorded at 81.0%, indicating that the majority of revenue remains after direct costs are deducted, while the operating margin of 61.3% and profit margin of 37.5% demonstrate strong operational efficiency and the ability to convert operations into net earnings. In terms of balance sheet leverage, the company holds $113.38M in cash against $1.52B in total debt, resulting in a debt-to-equity ratio of 97.57, which signifies a highly leveraged balance sheet reliant on debt financing for its asset expansion. The current ratio is 0.54, a metric that indicates the company's current assets are less than its current liabilities, suggesting a tight short-term liquidity position that requires careful management of cash flows to meet immediate obligations. Return on Equity is calculated at 9.6% and Return on Assets is 4.5%, metrics that reveal the effectiveness of management in utilizing shareholder equity and total assets to generate returns, though the lower ROA relative to ROE underscores the heavy impact of the company's high debt load on overall asset returns.
मूल्यांकन आकलन
The trailing twelve-month P/E ratio is 28.51, while the forward P/E is projected at 23.66, a difference that implies the market expects earnings to recover or grow significantly in the coming year to justify the lower forward multiple. The price-to-book ratio stands at 2.55, indicating that the market values the company at a substantial premium of 155% over its tangible book value, reflecting the intangible value of its portfolio or growth expectations. Alternative valuation metrics such as the price-to-sales ratio of 11.00 and an EV/EBITDA of 20.19 suggest that the stock is priced on high revenue multiples, which is common for REITs, yet the EV/EBITDA multiple indicates a relatively expensive valuation relative to its cash earnings power. The 52-week high is $91.38 and the 52-week low is $66.41, meaning the stock has experienced a trading range of nearly $25, with the current implied price sitting within this established volatility band. The beta value is 0.66, which explains that the stock exhibits lower price volatility relative to the broader market, moving with less intensity than the S&P 500 index during periods of market fluctuation.
Growth & Income
Revenue growth year-over-year is negative at -2.6%, while earnings growth year-over-year is negative at -43.0%, indicating that earnings are shrinking at a much faster rate than revenue, which implies rising operational costs or a contraction in the core business segment that is not fully offset by pricing power. As a dividend payer, the company offers a dividend yield of 4.2%, but the payout ratio is 120.5%, which is unsustainable given the current earnings contraction and suggests the company is paying out more in dividends than it is earning in net income. This high payout ratio, combined with the negative earnings growth, signals that the current dividend is likely being funded by cash reserves or restricted cash flow rather than sustainable earnings. Overall, the growth and income profile presents a complex picture of a high-yielding stock that is currently experiencing earnings contraction and a temporary deviation from sustainable dividend coverage levels.